Literature DB >> 32101022

Inhibition of the ox-LDL-Induced Pyroptosis by FGF21 of Human Umbilical Vein Endothelial Cells Through the TET2-UQCRC1-ROS Pathway.

Jiao-Jiao Chen1, Jun Tao1, Xiao-Lei Zhang2, Lin-Zhen Xia1, Jun-Fa Zeng1, Hai Zhang1, Dang-Heng Wei1, Yun-Cheng Lv3, Guo-Hua Li1, Zuo Wang1.   

Abstract

Fibroblast growth factor 21 (FGF21) is a hormone-like member of the FGF family that is associated with cell death in atherosclerosis. However, its underlying mechanisms remain unclear. In this study, the effect of FGF21 on endothelial cell pyroptosis and its potential mechanisms were investigated. Results showed that FGF21 inhibits oxidized low-density lipoprotein (ox-LDL)-induced pyroptosis and related molecular expression in human umbilical vein endothelial cells (HUVECs). Mitochondrial function was damaged by ox-LDL and restored by FGF21. A mechanism proved that ubiquinol cytochrome c reductase core protein I (UQCRC1) was downregulated by ox-LDL and upregulated by FGF21. Further, the silencing of UQCRC1 aggravated HUVEC pyroptosis and impaired mitochondrial function and reactive oxygen species (ROS) production. Moreover, Tet methylcytosine dioxygenase (TET2) was involved in the regulation of UQCRC1 expression and pyroptosis. In summary, FGF21 inhibited ox-LDL-induced HUVEC pyroptosis through the TET2-UQCRC1-ROS pathway.

Entities:  

Keywords:  Tet methylcytosine dioxygenase 2; atherosclerosis; fibroblast growth factor 21; human umbilical vein endothelial cells; pyroptosis; reactive oxygen species; ubiquinol cytochrome c reductase core protein I

Mesh:

Substances:

Year:  2020        PMID: 32101022     DOI: 10.1089/dna.2019.5151

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  8 in total

Review 1.  Pyroptosis, metabolism, and tumor immune microenvironment.

Authors:  Tiantian Du; Jie Gao; Peilong Li; Yunshan Wang; Qiuchen Qi; Xiaoyan Liu; Juan Li; Chuanxin Wang; Lutao Du
Journal:  Clin Transl Med       Date:  2021-08

Review 2.  Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis.

Authors:  Hui Jiang; Yongwen Zhou; Seyed M Nabavi; Amirhossein Sahebkar; Peter J Little; Suowen Xu; Jianping Weng; Jianjun Ge
Journal:  Front Cardiovasc Med       Date:  2022-06-01

3.  PCSK9 mediates the oxidative low‑density lipoprotein‑induced pyroptosis of vascular endothelial cells via the UQCRC1/ROS pathway.

Authors:  Junfa Zeng; Jun Tao; Linzhen Xi; Zuo Wang; Lushan Liu
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

4.  COCO/DAND5 inhibits developmental and pathological ocular angiogenesis.

Authors:  Natalija Popovic; Erika Hooker; Andrea Barabino; Anthony Flamier; Frédéric Provost; Manuel Buscarlet; Gilbert Bernier; Bruno Larrivée
Journal:  EMBO Mol Med       Date:  2021-02-15       Impact factor: 12.137

5.  LncRNA FENDRR Inhibits ox-LDL Induced Mitochondrial Energy Metabolism Disorder in Aortic Endothelial Cells via miR-18a-5p/PGC-1α Signaling Pathway.

Authors:  Guiming Wang; Yudong Yang; Honggang Ma; Liuming Shi; Wenbin Jia; Xing Hao; Weizong Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

6.  FGF21 attenuates high uric acid‑induced endoplasmic reticulum stress, inflammation and vascular endothelial cell dysfunction by activating Sirt1.

Authors:  Rong Ouyang; Xiaoqin Zhao; Rongping Zhang; Jing Yang; Siyin Li; Daihua Deng
Journal:  Mol Med Rep       Date:  2021-12-01       Impact factor: 2.952

7.  Exogenous spermine inhibits high glucose/oxidized LDL-induced oxidative stress and macrophage pyroptosis by activating the Nrf2 pathway.

Authors:  Yuxuan Qiu; Linna Li; Xiaohui Guo; Jiangwen Liu; Liang Xu; Yanbo Li
Journal:  Exp Ther Med       Date:  2022-03-01       Impact factor: 2.447

8.  Pulse Wave Velocity Is Associated with Increased Plasma oxLDL in Ageing but Not with FGF21 and Habitual Exercise.

Authors:  Shuen Yee Lee; Stephen F Burns; Kenneth K C Ng; David J Stensel; Liang Zhong; Frankie H Y Tan; Kar Ling Chia; Kai Deng Fam; Margaret M C Yap; Kwee Poo Yeo; Eric P H Yap; Chin Leong Lim
Journal:  Antioxidants (Basel)       Date:  2020-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.